Search Orphan Drug Designations and Approvals
-
Generic Name: | angiotensin 1-7 |
---|---|
Date Designated: | 06/17/2010 |
Orphan Designation: | To accelerate engraftment of hematopoietic cells (treatment of neutropenia, thrombocytopenia, lymphoma, and aneima)in hematopoietic stem cell transplants. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Tarix Pharmaceuticals, Ltd. 12 Bow Street Cambridge, Massachusetts 02138 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-